FDMT - 4DMT to Participate in Upcoming Investor Conferences | Benzinga
EMERYVILLE, Calif., Sept. 07, 2023 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT, 4DMT)), a clinical-stage biotherapeutics company harnessing the power of directed evolution for genetic medicines targeting large market diseases, announced today that management will present company overviews and participate in fireside chats at upcoming investor conferences in September and October. Members of the management team will also be available for one-on-one meetings in connection with these meetings.
H.C. Wainwright 25th Annual Global Investor Conference
| Presentation Date: |
| Monday, September 11, 2023 |
| Presentation Time: |
| 12:00 p.m. ET |
| Location: |
| Lotte New York Palace Hotel, New York, NY |
| Webcast Link: |
| Webcast |
Jefferies Cell & Genetic Medicine Summit